Hiroki Nishikawa

Summary

Affiliation: Japanese Red Cross
Country: Japan

Publications

  1. ncbi request reprint Risk factors associated with recurrent hemorrhage after the initial improvement of colonic diverticular bleeding
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Acta Gastroenterol Belg 76:20-4. 2013
  2. ncbi request reprint Clinical Efficacy of Non-transplant Therapies in Patients with Hepatocellular Carcinoma with Child-Pugh C Liver Cirrhosis
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Anticancer Res 34:3039-44. 2014
  3. pmc The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Gastroenterol Res Pract 2013:430438. 2013
  4. pmc A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatin
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Case Rep Oncol 4:327-35. 2011
  5. doi request reprint Radiofrequency ablation for hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka, Japan
    Int J Hyperthermia 29:558-68. 2013
  6. doi request reprint Surgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patients
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Eur J Gastroenterol Hepatol 25:912-9. 2013
  7. doi request reprint Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka, 543 0027, Japan
    J Gastroenterol 48:951-65. 2013
  8. doi request reprint Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka 543 0027, Japan
    Oncol Rep 30:91-8. 2013
  9. ncbi request reprint Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Japan
    J Gastrointestin Liver Dis 22:173-81. 2013
  10. ncbi request reprint Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Anticancer Res 33:2211-9. 2013

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Risk factors associated with recurrent hemorrhage after the initial improvement of colonic diverticular bleeding
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Acta Gastroenterol Belg 76:20-4. 2013
    ..Close observation after the initial improvement of colonic diverticular bleeding is needed, especially in elderly patients or patients with history of hypertension or renal deficiency...
  2. ncbi request reprint Clinical Efficacy of Non-transplant Therapies in Patients with Hepatocellular Carcinoma with Child-Pugh C Liver Cirrhosis
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Anticancer Res 34:3039-44. 2014
    ..95 years vs. 0.17 years, p=0.01). Conclusion: In patients with HCC with Child-Pugh C cirrhosis, those treated with non-transplant therapies might have longer survival than untreated patients. ..
  3. pmc The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Gastroenterol Res Pract 2013:430438. 2013
    ..899) and surgery-related serious adverse events (P = 0.813). Conclusions. Obesity itself did not affect survival in patients with HCV-related HCC after curative SR...
  4. pmc A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatin
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Case Rep Oncol 4:327-35. 2011
    ..No serious adverse events occurred during the course of treatment with TAI and miriplatin. Therefore, we suggest that TAI with miriplatin is a safe and effective treatment option for advanced HCCs refractory to TAI with epirubicin...
  5. doi request reprint Radiofrequency ablation for hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka, Japan
    Int J Hyperthermia 29:558-68. 2013
    ..In this review, we primarily focus on percutaneous RFA therapy for HCC and refer to current knowledge and future perspectives for this therapy. We also discuss new emerging ablation techniques...
  6. doi request reprint Surgical resection for hepatocellular carcinoma: clinical outcomes and safety in elderly patients
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Eur J Gastroenterol Hepatol 25:912-9. 2013
    ..The aim of this study was to compare the clinical outcomes and safety of surgical resection for hepatocellular carcinoma between patients older than 75 years of age (elderly group) and those younger than 75 years (control group)...
  7. doi request reprint Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka, 543 0027, Japan
    J Gastroenterol 48:951-65. 2013
    ..The aim of this study was to measure the overall survival (OS), the recurrence free survival (RFS), and the distant recurrence (DR) rate for each R grade (A-D), and to examine the relationship between clinical outcome and R grading...
  8. doi request reprint Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka 543 0027, Japan
    Oncol Rep 30:91-8. 2013
    ..In conclusion, anti-HBc-positivity is not a useful predictor for survival of patients with HCV-related HCC after curative SR...
  9. ncbi request reprint Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Japan
    J Gastrointestin Liver Dis 22:173-81. 2013
    ..The impact of obesity on survival after curative treatment for non-B non-C hepatocellular carcinoma (NBNC-HCC) remains unclear. This study examined the prognostic impact of obesity in patients who received curative therapy for NBNC-HCC...
  10. ncbi request reprint Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Anticancer Res 33:2211-9. 2013
    ..We aimed to examine the relationship between antibodies to hepatitis B core antigen (anti-HBc) positivity and survival in patients with non-B non-C hepatocellular carcinoma (NBNC-HCC) who underwent curative treatment...
  11. doi request reprint The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka, Japan
    J Clin Gastroenterol 47:359-66. 2013
    ..5 g/dl...
  12. ncbi request reprint Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Anticancer Res 33:1181-8. 2013
    ..We examined the prognostic value of pre-treatment C-reactive protein (CRP) after surgical resection (SR) for hepatocellular carcinoma (HCC)...
  13. doi request reprint Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka, Japan
    Int J Oncol 42:151-60. 2013
    ..In conclusion, TACE is a safe procedure in patients with HCC, and the efficacy of TACE prior to surgery may be associated with clinical outcomes after SR...
  14. pmc Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka 543 0027, Japan
    World J Gastroenterol 18:1379-84. 2012
    ..To examine the significance of branched-chain amino acid (BCAA) treatment before transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)...
  15. ncbi request reprint Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients
    Hiroki Nishikawa
    Department of Gastroeneterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    J Gastrointestin Liver Dis 21:397-405. 2012
    ..We aimed to compare clinical outcomes and safety of radiofrequency ablation (RFA) in single hepatocellular carcinoma (HCC) patients aged > 75 years (elderly group) versus patients aged < 75 years (control group)...
  16. ncbi request reprint Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    Anticancer Res 32:5059-65. 2012
    ..To compare the overall survival (OS) in patients without recurrent hepatocellular carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with recurrence, treated with repeat-RFA...
  17. doi request reprint Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Oncol Rep 28:835-40. 2012
    ..281). In conclusion, our study results suggested that HCV infection might not influence the clinical course in DLBCL patients who receive rituximab-containing immunochemotherapy...
  18. doi request reprint Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka 543 0027, Japan
    Int J Oncol 41:903-9. 2012
    ..048), although there was no significant difference in terms of the LTP (P=0.145). We concluded that TAI-EML prior to RFA appears to be useful in reducing post-RFA IDR and may contribute to improved survival rates...
  19. pmc The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    BMC Res Notes 5:135. 2012
    ..We also examined the factors contributing to a sustained virological response...
  20. doi request reprint Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 30 Fudegasaki Cho, Tennoji ku, Osaka 543 0027, Japan
    J Gastroenterol 46:1418-26. 2011
    ..We measured the local recurrence rate for each radicality grade to evaluate the significance of the grading system in assessing the therapeutic effectiveness of RFA and predicting local tumor progression...
  21. pmc Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Fudegasaki cho, Tennoji ku, Japan
    BMC Gastroenterol 11:143. 2011
    ..The purpose of this investigation was to compare the outcome of percutaneous radiofrequency thermal ablation therapy (PRFA) with surgical resection (SR) in the treatment of single and small hepatocellular carcinoma (HCC)...
  22. doi request reprint Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study
    Yukio Osaki
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, 5 53 Fudegasaki cho, Tennoji ku, Osaka 543 8555, Japan
    J Gastroenterol 47:444-51. 2012
    ..The aim of this study was to identify predictive markers for the risk of HCC incidence in chronic hepatitis C patients receiving interferon therapy...
  23. ncbi request reprint [Case of moderately differentiated hepatocellular carcinoma with gastric metastasis]
    Kiyoaki Hatano
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital
    Nihon Shokakibyo Gakkai Zasshi 105:404-11. 2008
    ....
  24. doi request reprint Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report
    Tadashi Inuzuka
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Oncology 81:152-7. 2011
    ..To our knowledge, this is the first time a female treated with sorafenib alone for HCC has had a CR...
  25. ncbi request reprint [A case of α-fetoprotein-producing hepatoid adenocarcinoma of the stomach with spontaneous rupture of multiple liver metastases]
    Haruhiko Takeda
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital
    Nihon Shokakibyo Gakkai Zasshi 110:1625-32. 2013
    ..Hepatoid adenocarcinomas are hypervascular, rapidly growing tumors that may result in the spontaneous rupture of metastatic liver lesions. Transarterial embolization may be a feasible option for the treatment of these ruptured tumors. ..
  26. ncbi request reprint [Seven cases of gemcitabine-induced lung injury during treatment for pancreatic or biliary tract cancers]
    Takehiko Tsumura
    Dept of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Japan
    Gan To Kagaku Ryoho 36:785-8. 2009
    ..Five cases had pulmonary emphysema, 2 had metastatic lung tumor as underlying pulmonary lesions, and these were assumed to have been important risk factors for drug-induced interstitial lung injury during gemcitabine treatment...
  27. ncbi request reprint Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: Propensity score matching analysis
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka 543 0027, Japan
    Int J Oncol 45:1082-90. 2014
    ..017). In other subgroup analyses, no significant difference in the two groups was found in terms of OS. In conclusion, early interventional therapies using BCAA granules may be effective in some selected HCC patients. ..
  28. doi request reprint Clinical characteristics of collagenous colitis with linear ulcerations
    Sumio Saito
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan
    Dig Endosc 26:69-76. 2014
    ..The aim of the present study was to compare the clinical and pathological features, including the thickness of CB, in CC patients with and without LU...
  29. doi request reprint Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka 543 0027, Japan
    Oncol Rep 31:65-72. 2014
    ..Treatment mortality was 0% in the two groups. In conclusion, patients with intermediate-stage HCC had a comparable prognosis when treated with TACI or TACE. ..
  30. ncbi request reprint [A case of focal nodular hyperplasia presenting corona enhancement on single-level dynamic CT during hepatic arteriography]
    Ryuichi Kita
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital
    Nihon Shokakibyo Gakkai Zasshi 105:550-7. 2008
    ..In our case, the drainage flow from the nodule may have been visualized as corona enhancement via the pathway from the sinusoid in the nodular periphery to the one in the adjacent and contiguous parenchyma...
  31. ncbi request reprint [Three cases of hepatocellular carcinoma with nodules showing different signal intensities in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI]
    Ryuichi Kita
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital
    Nihon Shokakibyo Gakkai Zasshi 111:940-7. 2014
    ..The expression of excreting transporters is usually characterized by passive correspondence to OATP8 expression levels; nevertheless, it sometimes shows expression independent of OATP8. ..
  32. ncbi request reprint Prominent hypereosinophilia with disseminated intravascular coagulation as an unusual presentation of advanced gastric cancer
    Haruhiko Takeda
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Japan
    Intern Med 53:563-9. 2014
    ..The primary symptoms of DIC and eosinophilia were both considered to be caused by AGC, and we successfully treated the patient's critical condition. ..
  33. ncbi request reprint [A case of primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype: comparison of hemodynamics and histopathology]
    Ryuichi Kita
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Japan
    Nihon Shokakibyo Gakkai Zasshi 107:449-60. 2010
    ..Six months after the resection of the tumor, swollen abdominal lymph nodes were observed on US and CT, which aspiration needle biopsy showed to be metastasis of a hepatic tumor...
  34. doi request reprint Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study
    Soo Ki Kim
    Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Digestion 84:43-9. 2011
    ..To clarify risk factors and clinical features of both hepatitis B surface antigen and anti-HCV negative hepatocellular carcinoma (NBNC-HCC)...
  35. ncbi request reprint Double primary cancers: intrahepatic cholangiocarcinoma with myocardial metastases and lung squamous cell carcinoma
    Takaaki Murakami
    Department of Internal Medicine, Osaka Red Cross Hospital, Japan
    Intern Med 51:2329-35. 2012
    ..A hilar nodule in the lung was revealed to be lung squamous cell carcinoma. This was a rare case of intrahepatic cholangiocarcinoma with myocardial metastases and lung squamous cell carcinoma...
  36. ncbi request reprint Non-B, non-C hepatocellular carcinoma (Review)
    Hiroki Nishikawa
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji ku, Osaka 543 0027, Japan
    Int J Oncol 43:1333-42. 2013
    ..In this review, we primarily focus on clinical aspects of NBNC-HCC and refer to our current knowledge of this cancer...
  37. ncbi request reprint [Tuberculous peritonitis diagnosed by laparoscope, differentiated from Fitz-Hugh-Curtis syndrome]
    Tomoko Kawanishi
    Department of Gastroenterology, Osaka Red Cross Hospital, Osaka
    Nihon Naika Gakkai Zasshi 96:2801-3. 2007
  38. ncbi request reprint [A case of nodule-in-nodule type HCC presenting corona enhancement within the outer tumor on single-level dynamic CT during hepatic arteriography]
    Ryuichi Kita
    Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital
    Nihon Shokakibyo Gakkai Zasshi 104:837-9. 2007